Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 86150R107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 5,310,033 · Class: 9.99%
- Roderick Wong, M.D.
Shares: 5,310,033 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020494
- Form type
- SCHEDULE 13G/A
- Filer
- RTW INVESTMENTS, LP
- CIK
- CIK 1493215
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership